Skip to main content

Photolitec wins NIH grant, FDA approval for clinical trials

The company, a spin-off from Roswell Park Comprehensive Cancer Center, hopes to begin human clinical trials in the coming months, pending institutional review board approvals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.